NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors

NaviFUS’ focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA). It will be initiated shortly at …
( read original story …)

---